Mirum Pharmaceuticals, Inc. (MIRM) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $521.31M | +54.7% |
| 2024 | $336.89M | +80.8% |
| 2023 | $186.37M | +141.8% |
| 2022 | $77.06M | +302.7% |
| 2021 | $19.14M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $521.31M | +54.7% |
| 2024 | $336.89M | +80.8% |
| 2023 | $186.37M | +141.8% |
| 2022 | $77.06M | +302.7% |
| 2021 | $19.14M | — |